Switch to:
More From Other Websites
NYSE stocks posting largest percentage decreases Oct 24 2014
Halozyme's PEGPH20 Receives FDA Orphan Drug Designation Oct 07 2014
Alexion Pharmaceuticals (ALXN) in Focus: Stock Rises 6.0% Oct 06 2014
Weakness Seen in Vital Therapies (VTL): Stock Falls 6.3% Oct 06 2014
CorMedix Files IND Application for Neutrolin in the US Sep 30 2014
Ambit Biosciences (AMBI) Soars: Stock Adds 87.1% Sep 30 2014
Alimera/pSivida's Iluvien Receives FDA Approval for DME Sep 29 2014
Repros Therapeutics (RPRX) Worth Watching: Stock Up 17% Sep 29 2014
Celldex (CLDX) Up on Pilot Study Initiation on CDX-301 Sep 26 2014
Rexahn Pharmaceuticals (RNN) Jumps: Stock Gains 10.2% Sep 26 2014
Cambrex (CBM) Is in Oversold Territory: What's Next? Sep 25 2014
Acceleron Pharma (XLRN) Jumps: Stock Rises 12.8% Sep 24 2014
Sangamo Biosciences (SGMO) Jumps: Stock Rises 5.4% Sep 24 2014
Integra Freedom Wrist's Commercial Availability Falls Flat Sep 23 2014
OncoMed Pharmaceuticals (OMED) Jumps: Stock Up 5.4% Sep 23 2014
Integra to Buy Medtronic's MicroFrance, Xomed; Shares Up Sep 22 2014
Halozyme's PEGPH20 Study S1313 Clinical Hold Lifted by FDA Sep 19 2014
ImmunoCellular Therapeutics (IMUC) Jumps: Stock Up 9% Sep 18 2014
Halozyme Therapeutics (HALO) Jumps: Stock Up 9.3% Sep 18 2014
Alder Biopharmaceuticals (ALDR) in Focus: Stock Up 5.2% Sep 18 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK